Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPD
Chronic lung disease: ‘Triple’ therapy could prove beneficial A dual bronchodilator therapy taken together with corticosteroid inhalers may benefit patients with severe chronic lung disease. Bronchodilator drugs relax the lungs and widen airways in patients with chronic obstructive pulmonary disease...
Guardado en:
Autores principales: | Anthony D’Urzo, Dave Singh, Esther Garcia Gil |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/654a3cf29b0b4a31be51af762d98abe5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
por: James D. Chalmers, et al.
Publicado: (2017) -
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
por: Ian D. Pavord, et al.
Publicado: (2017) -
Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review
por: Sven L. Klijn, et al.
Publicado: (2017) -
Critical inhaler technique errors in Swedish patients with COPD: a cross-sectional study analysing video-recorded demonstrations
por: Johanna Sulku, et al.
Publicado: (2021) -
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
por: Sandeep Bansal, et al.
Publicado: (2021)